Focus Partners Wealth

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1542153 ST LOUIS, MO

Position in REGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$12,702,974

+$3,513,090 QoQ

Shares Held

16,441

+38.1% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 21.6679846706004.ToString("F0")% Shared 0.ToString("F0")% None 78.3320153293996.ToString("F0")%

Healthcare · as of Mar 31, 2026

Focus Partners Wealth holds $172,241,737 across 69 Biotechnology names. REGN ranks #3 (7.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	131,435	$58,690,984
2	CELC	Celcuity Inc.	233,390	$26,639,134
3	REGN	Regeneron Pharmaceuticals, Inc. This page	16,441	$12,702,974
4	IONS	Ionis Pharmaceuticals Inc	165,544	$12,430,698
5	HALO	Halozyme Therapeutics, Inc.	169,286	$10,940,954
6	INCY	Incyte Corp	116,075	$10,924,979
7	RPRX	Royalty Pharma plc	116,250	$5,576,512
8	EXEL	Exelixis, Inc.	107,776	$4,622,512

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$12,702,974	16,441	+38.1%	Shares	Sole	2026-05-15
2025-12-31	$9,189,884	11,906	+30.1%	Shares	Sole	2026-02-13
2025-09-30	$5,145,895	9,152	+70.5%	Shares	Sole	2025-11-14
2025-06-30	$2,817,675	5,367	-9.7%	Shares	Sole	2025-08-14
2025-03-31	$3,771,131	5,946	-35.6%	Shares	Sole	2025-05-20
2024-12-31	$6,571,956	9,226	+210.5%	Shares	Sole	2025-05-29
2024-09-30	$3,123,234	2,971	-56.9%	Shares	Sole	2024-11-14
2024-06-30	$7,244,749	6,893	+38.1%	Shares	Sole	2024-08-15
2024-03-31	$4,805,712	4,993	+86.7%	Shares	Sole	2024-05-16
2023-12-31	$2,348,547	2,674	—	Shares	Sole	2024-02-15
No filing history on record for this holder in this stock.